Understanding Your Cancer Treatment Options with PD-L1 Testing
When you’re facing a cancer diagnosis, every piece of information matters. The PD-L1 SP263 Immunohistochemistry Test provides crucial insights that could significantly impact your treatment journey. This specialised test helps determine whether immunotherapy – one of the most promising advances in cancer treatment – might be effective for your specific cancer type.
What Does the PD-L1 SP263 Test Detect?
This test examines the PD-L1 protein levels in your cancer cells. Think of PD-L1 as a “don’t attack me” signal that cancer cells sometimes use to hide from your immune system. When cancer cells have high levels of PD-L1, they can trick your body’s natural defences into leaving them alone.
Immunotherapy drugs work by blocking this PD-L1 signal, essentially taking the blindfold off your immune system so it can recognise and attack cancer cells effectively. Our test helps your oncologist understand if this approach could work for you.
Who Should Consider This Test?
This test is particularly important if you’ve been diagnosed with:
- Lung cancer (non-small cell lung cancer)
- Bladder cancer
- Head and neck cancers
- Other solid tumours being considered for immunotherapy
If your oncologist is discussing immunotherapy as a potential treatment option, this test provides the scientific evidence needed to make an informed decision about whether this approach is right for your specific cancer.
Why This Test Matters for Your Cancer Journey
Getting the right information at the right time can make all the difference in your cancer treatment. This test offers:
- Personalised Treatment Planning: Helps determine if immunotherapy could be effective for your specific cancer
- Avoid Unnecessary Treatment: Prevents spending time and resources on treatments that may not work
- Maximise Treatment Success: Increases the likelihood of choosing the most effective therapy from the start
- Peace of Mind: Provides scientific evidence to support treatment decisions
Understanding Your Test Results
Your results will show the percentage of cancer cells expressing PD-L1. Don’t worry about interpreting these numbers yourself – your oncologist will explain what they mean for your specific situation:
- High PD-L1 Expression: Suggests your cancer may respond well to immunotherapy
- Low PD-L1 Expression: Indicates other treatment options might be more appropriate
- Your oncologist will consider these results alongside other factors to create your personalised treatment plan
Remember, this is one piece of information that helps guide your treatment journey, not a definitive prediction of outcomes.
Transparent Pricing – No Surprises
| Test | Regular Price | Special Price | Savings |
|---|---|---|---|
| PD-L1 SP263 Immunohistochemistry Test | R2,350 | R1,650 |
This investment in precise diagnostic information could help avoid costly, ineffective treatments and guide you toward the most appropriate therapy for your cancer.
Fast, Reliable Results When You Need Them Most
- Sample Processing: Daily by 6 PM
- Standard Results: 5 days for blocks and tissue biopsies
- Complex Cases: 7 days for large, complex tissue samples
We understand that waiting for results can be stressful, which is why we’ve optimised our processes to deliver your information as quickly as possible without compromising accuracy.
What You Need to Provide
To ensure accurate testing, please provide:
- Tumor tissue in 10% formal-saline OR formalin fixed paraffin embedded block
- A copy of your histopathology report
- Site of biopsy information
- Your complete clinical history
Shipping: Ship samples at room temperature. Our team will guide you through the process to ensure everything arrives safely.
Why Trust Oracle Genomics?
Nationwide Coverage
Accessible testing across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
Expert Collaboration
Working closely with oncologists and pathologists to ensure accurate interpretation
Advanced Methodology
Using Ventana SP263 immunohistochemistry – the gold standard for PD-L1 testing
Patient-Focused Care
We understand the emotional journey and provide compassionate, clear communication
Take the Next Step in Your Cancer Journey
Don’t leave your treatment decisions to chance. Get the precise information you need to make informed choices about your cancer care.
Early testing can guide treatment decisions when they matter most. Many patients find that having this information early in their journey reduces anxiety and helps them feel more in control of their treatment path.
